"Recombinant Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins prepared by recombinant DNA technology.
| Descriptor ID |
D011994
|
| MeSH Number(s) |
D12.776.828
|
| Concept/Terms |
Recombinant Proteins- Recombinant Proteins
- Proteins, Recombinant
- Proteins, Biosynthetic
- Biosynthetic Proteins
Proteins, Recombinant DNA- Proteins, Recombinant DNA
- DNA Proteins, Recombinant
- Recombinant DNA Proteins
- DNA Recombinant Proteins
- Proteins, DNA Recombinant
- Recombinant Proteins, DNA
|
Below are MeSH descriptors whose meaning is more general than "Recombinant Proteins".
Below are MeSH descriptors whose meaning is more specific than "Recombinant Proteins".
This graph shows the total number of publications written about "Recombinant Proteins" by people in this website by year, and whether "Recombinant Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 10 | 10 |
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 1 | 8 | 9 |
| 2003 | 1 | 11 | 12 |
| 2004 | 1 | 23 | 24 |
| 2005 | 5 | 19 | 24 |
| 2006 | 1 | 21 | 22 |
| 2007 | 1 | 13 | 14 |
| 2008 | 0 | 13 | 13 |
| 2009 | 2 | 13 | 15 |
| 2010 | 0 | 13 | 13 |
| 2011 | 3 | 10 | 13 |
| 2012 | 2 | 10 | 12 |
| 2013 | 0 | 9 | 9 |
| 2014 | 0 | 16 | 16 |
| 2015 | 1 | 10 | 11 |
| 2016 | 2 | 16 | 18 |
| 2017 | 22 | 169 | 191 |
| 2018 | 29 | 128 | 157 |
| 2019 | 5 | 51 | 56 |
| 2020 | 4 | 46 | 50 |
| 2021 | 4 | 28 | 32 |
To return to the timeline, click here.
Below are the most recent publications written about "Recombinant Proteins" by people in Profiles.
-
Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial. Ann Med. 2021 12; 53(1):391-401.
-
A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques. Emerg Microbes Infect. 2021 Dec; 10(1):342-355.
-
BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19. J Gerontol A Biol Sci Med Sci. 2021 09 13; 76(10):1775-1783.
-
Evolutionary loss of inflammasomes in the Carnivora and implications for the carriage of zoonotic infections. Cell Rep. 2021 08 24; 36(8):109614.
-
Development and clinical evaluation of a rapid antibody lateral flow assay for the diagnosis of SARS-CoV-2 infection. BMC Infect Dis. 2021 Aug 23; 21(1):860.
-
Cell-Free Hemoglobin Does Not Attenuate the Effects of SARS-CoV-2 Spike Protein S1 Subunit in Pulmonary Endothelial Cells. Int J Mol Sci. 2021 Aug 22; 22(16).
-
S-acylation of SARS-CoV-2 spike protein: Mechanistic dissection, in vitro reconstitution and role in viral infectivity. J Biol Chem. 2021 10; 297(4):101112.
-
Efficacy and safety of pegylated interferon-a2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study. Int J Infect Dis. 2021 Oct; 111:281-287.
-
Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing. Structure. 2021 12 02; 29(12):1382-1396.e6.
-
Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice. Viruses. 2021 08 12; 13(8).